FOXA Q1 2026 Earnings EPS Beat by Over 33 Drives Positive Market Reaction ESLA Q1 2026 Earnings EPS Misses Estimates by Wide Margin as ClinicalStage Biotech Continues RD Spending EBMT Q1 2026 Earnings EPS Beats Estimates Stock Edges Higher Nabors Industries Q1 2026 Earnings Strong EPS Beat Amid Challenging Market SVRA Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Continues Pipeline Development GTX Q1 2026 Earnings EPS Surprise Lifts Results but Stock Slips